The facility, which will be the drugmaker’s first end-to-end antibody-drug conjugate production site, will be supported by the Singapore Economic Development Board.
Certain genes may identify patients with obesity who are most likely to respond strongly to Novo Nordisk’s weight-loss drug Wegovy, researchers reported today.
Peregrine Market Access, a full-service consulting, communications, and commercialization partner for the life sciences industry, has promoted Alyson Popa to account director, Jennifer Sparano to senior vice president, director of corporate communications, and Stacey Thomas to vice president, director of project management.
According to GlobalData, more than 190 million people currently live with type 2 diabetes and/or obesity in seven major markets, and the numbers will be growing at an annual growth rate (AGR) of 1.35% and 0.57% for type 2 diabetes and obesity, respectively, in the next 10 years.
Since taking the helm in 2023, Anderson has embarked on a radical departure from the traditional structure of large pharma companies. Will getting rid of management layers fix Bayer?
For the first time, beginning this summer, care-receivers will have the ability to add a caregiver to their Uber profile, empowering them to request and monitor rides and deliveries, as well as apply the care-receiver’s eligible health benefits to pay. The solution is designed to help patients maximize their ancillary healthcare benefits and to improve the care experience for caregivers and care-receivers alike.